{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:38Z","timestamp":1786996058297,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.psc.2007.07.006","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T09:13:15Z","timestamp":1196154795000},"page":"739-759","source":"Crossref","is-referenced-by-count":17,"title":["Hematologic Problems in Psychosomatic Medicine"],"prefix":"10.1016","volume":"30","author":[{"given":"Madeleine","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Axelrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olu","family":"Oyesanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri D.","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth J.","family":"Shakin Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2007.07.006_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.psc.2007.07.006_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2003.1.62","article-title":"Update on cobalamin, folate, and homocysteine","volume":"1","author":"Carmel","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.psc.2007.07.006_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM198806303182604","article-title":"Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis","volume":"318","author":"Lindenbaum","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ageing\/afl150","article-title":"Vitamin B12 deficiency in the aged: a population-based study","volume":"36","author":"Loikas","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.psc.2007.07.006_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","article-title":"Homocysteine and folate as risk factors for dementia and Alzheimer disease","volume":"82","author":"Ravaglia","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"Bottiglieri","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cmaj.1031155","article-title":"Vitamin B12 (cobalamin) deficiency in elderly patients","volume":"171","author":"Andres","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.psc.2007.07.006_bib10","doi-asserted-by":"crossref","first-page":"614S","DOI":"10.1093\/ajcn\/71.2.614s","article-title":"B vitamins, homocysteine, and neurocognitive function in the elderly","volume":"71","author":"Selhub","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1176\/ajp.154.3.426","article-title":"Folate, vitamin B12, and homocysteine in major depressive disorder","volume":"154","author":"Fava","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clnu.2005.08.014","article-title":"Vitamin B12 and folate serum levels in newly admitted psychiatric patients","volume":"25","author":"Lerner","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM199711133372007","article-title":"Pernicious anemia","volume":"337","author":"Toh","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.amjmed.2005.02.026","article-title":"Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment","volume":"118","author":"Andres","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ageing\/afj042","article-title":"Metformin-related vitamin B12 deficiency","volume":"35","author":"Liu","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.psc.2007.07.006_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/diacare.23.9.1227","article-title":"Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin","volume":"23","author":"Bauman","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psc.2007.07.006_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jclinepi.2003.08.015","article-title":"A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults","volume":"57","author":"Valuck","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.psc.2007.07.006_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2190\/C2MU-AHVC-3092-X2TB","article-title":"Acute dementia with delirium due to vitamin B12 deficiency: a case report","volume":"32","author":"Lerner","year":"2002","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.psc.2007.07.006_bib19","first-page":"560","article-title":"Psychiatric manifestations of vitamin B12 deficiency: a case report","volume":"29","author":"Durand","year":"2003","journal-title":"Encephale"},{"key":"10.1016\/j.psc.2007.07.006_bib20","series-title":"Psychiatric care of the medical patient","first-page":"833","article-title":"Hematologic disorders","author":"Kunkel","year":"2000"},{"key":"10.1016\/j.psc.2007.07.006_bib21","series-title":"Kaplan and Sadock's synopsis of psychiatry","author":"Sadock","year":"2003"},{"key":"10.1016\/j.psc.2007.07.006_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.324.7352.1512","article-title":"Folic acid, ageing, depression, and dementia","volume":"324","author":"Reynolds","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.psc.2007.07.006_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.328.7433.211","article-title":"Is folic acid the ultimate functional food component for disease prevention?","volume":"328","author":"Lucock","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.psc.2007.07.006_bib24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/WNL.56.9.1188","article-title":"Vitamin B(12) and folate in relation to the development of Alzheimer's disease","volume":"56","author":"Wang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2007.07.006_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-0327(90)90093-N","article-title":"Red cell folate concentrations in psychiatric patients","volume":"19","author":"Carney","year":"1990","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psc.2007.07.006_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004514","article-title":"Folic acid with or without vitamin B12 for cognition and dementia","volume":"4","author":"Malouf","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2007.07.006_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/07315724.2005.10719474","article-title":"The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States","volume":"24","author":"Dietrich","year":"2005","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib28","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/jn\/131.12.3277","article-title":"Folic acid fortification increases red blood cell folate concentrations in the Framingham study","volume":"131","author":"Choumenkovitch","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib29","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/jn\/132.9.2792","article-title":"Folic acid intake from fortification in United States exceeds predictions","volume":"132","author":"Choumenkovitch","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib30","series-title":"US Preventative Services Task Force. Guide to Clinical Preventative Services","year":"1996"},{"key":"10.1016\/j.psc.2007.07.006_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1701-2163(16)30248-1","article-title":"The use of folic acid for the prevention of neural tube defects and other congenital anomalies","volume":"25","author":"Wilson","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.psc.2007.07.006_bib32","first-page":"806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"Am J\u00a0Clin Nutr"},{"key":"10.1016\/j.psc.2007.07.006_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4088\/JCP.v65n0811","article-title":"Serum folate, vitamin B12, and homocysteine in major depressive disorder, part 2: predictors of relapse during the continuation phase of pharmacotherapy","volume":"65","author":"Papakostas","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0327(00)00153-1","article-title":"Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial","volume":"60","author":"Coppen","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psc.2007.07.006_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2007.07.006_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archneur.64.1.86","article-title":"Relation of higher folate intake to lower risk of Alzheimer disease in the elderly","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2007.07.006_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-2006-9410","article-title":"Dietary folate and vitamins B-12 and B-6 not associated with incident alzheimer's disease","volume":"9","author":"Morris","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.psc.2007.07.006_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinte.167.1.21","article-title":"Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials","volume":"167","author":"Balk","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.psc.2007.07.006_bib39","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jpepsy\/25.5.287","article-title":"Factors that influence adolescent adaptation to sickle cell disease","volume":"25","author":"Burlew","year":"2000","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.psc.2007.07.006_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/01612840500280745","article-title":"Sickle cell disease: a stigmatizing condition that may lead to depression","volume":"26","author":"Jenerette","year":"2005","journal-title":"Issues Ment Health Nurs"},{"key":"10.1016\/j.psc.2007.07.006_bib42","unstructured":"Levenson JL, McClish DK, Dahman BA, et\u00a0al. Depression and anxiety in adults with sickle cell disease: the PiSCES. Psychosom Med, in press."},{"key":"10.1016\/j.psc.2007.07.006_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11920-007-0080-0","article-title":"Anxiety and depression in children and adolescents with sickle cell disease","volume":"9","author":"Benton","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.psc.2007.07.006_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.2005.05500.x","article-title":"Psychological complications in sickle cell disease","volume":"129","author":"Anie","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.psc.2007.07.006_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archpedi.1994.02170050015003","article-title":"Depression in children and adolescents with sickle-cell disease","volume":"148","author":"Yang","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.psc.2007.07.006_bib46","first-page":"10","article-title":"Physical growth, sexual maturation, body image and sickle cell disease","volume":"92","author":"Cepeda","year":"2000","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.psc.2007.07.006_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jpepsy\/11.3.429","article-title":"Psychological and social concomitants of sickle cell anemia in adolescents","volume":"11","author":"Morgan","year":"1986","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.psc.2007.07.006_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1749-6632.1989.tb24164.x","article-title":"Adjustment and coping in adolescents with sickle cell disease","volume":"565","author":"Hurtig","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.psc.2007.07.006_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/jpmn.2001.26297","article-title":"American Pain Society. Pain management in sickle cell disease","volume":"2","author":"Jacob","year":"2001","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.psc.2007.07.006_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib51","volume":"Vol. 11","author":"Ballas","year":"1998"},{"key":"10.1016\/j.psc.2007.07.006_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-116-5-364","article-title":"Treating sickle cell pain like cancer pain","volume":"116","author":"Brookoff","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.psc.2007.07.006_bib53","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/00002508-200207001-00010","article-title":"Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain","volume":"18","author":"Chapman","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.psc.2007.07.006_bib54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians' attitude and practices in sickle cell disease pain management","volume":"21","author":"Labbe","year":"2005","journal-title":"J Palliat Care"},{"key":"10.1016\/j.psc.2007.07.006_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/apnr.2001.26783","article-title":"Nurses' attitudes and practices in sickle cell pain management","volume":"14","author":"Pack-Mabien","year":"2001","journal-title":"Appl Nurs Res"},{"key":"10.1016\/j.psc.2007.07.006_bib56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00019-5","article-title":"Sickle cell-related pain: perceptions of medical practitioners","volume":"14","author":"Shapiro","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.psc.2007.07.006_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","article-title":"Opioid pseudoaddiction\u2014an iatrogenic syndrome","volume":"36","author":"Weissman","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.psc.2007.07.006_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2190\/7XMD-L45D-47DH-7MEC","article-title":"Drug addiction in sickle cell disease: case report","volume":"33","author":"Alao","year":"2003","journal-title":"Int\u00a0J\u00a0Psychiatry Med"},{"key":"10.1016\/j.psc.2007.07.006_bib59","unstructured":"Levenson JL, McClish DK, Dahman BA, et\u00a0al. Alcohol abuse in sickle cell disease: the PiSCES project. Am J Addict, in press."},{"key":"10.1016\/j.psc.2007.07.006_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mrdd.20115","article-title":"Sickle cell disease as a neurodevelopmental disorder","volume":"12","author":"Schatz","year":"2006","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.psc.2007.07.006_bib61","series-title":"Sickle cell disease: basic principles and clinical practice","first-page":"599","article-title":"Neurological complcations","author":"Adams","year":"1994"},{"key":"10.1016\/j.psc.2007.07.006_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(94)90196-1","article-title":"The spectrum of epilepsy in sickle cell anemia","volume":"123","author":"Liu","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.psc.2007.07.006_bib63","first-page":"498","article-title":"Functional outcomes of children with sickle-cell disease affected by stroke","volume":"72","author":"Hariman","year":"1991","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.psc.2007.07.006_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/088307380201700204","article-title":"Kindergarten readiness skills in children with sickle cell disease: evidence of early neurocognitive damage?","volume":"17","author":"Steen","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.psc.2007.07.006_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/A:1013172913880","article-title":"Barriers to effective mental health services for African Americans","volume":"3","author":"Snowden","year":"2001","journal-title":"Ment Health Serv Res"},{"key":"10.1016\/j.psc.2007.07.006_bib66","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2007.07.006_bib67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1056-4993(03)00025-7","article-title":"Psychological aspects of hematologic diseases","volume":"12","author":"Casey","year":"2003","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.psc.2007.07.006_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mop.0000152002.03019.4c","article-title":"Hemophilia management: Optimizing treatment based on patient needs","volume":"17","author":"Manco-Johnson","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.psc.2007.07.006_bib69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the international society on thrombosis and haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"issue":"Suppl 4","key":"10.1016\/j.psc.2007.07.006_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2004.01002.x","article-title":"Models for psychosocial services in the developed and developing world","volume":"10","author":"Spilsbury","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.psc.2007.07.006_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2516.2003.00723.x","article-title":"Analgesic use and pain coping among patients with haemophilia","volume":"9","author":"Elander","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.psc.2007.07.006_bib72","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1528-1167.2006.00587.x","article-title":"Valproate-associated coagulopathies are frequent and variable in children","volume":"47","author":"Gerstner","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.psc.2007.07.006_bib73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jpepsy\/jsg004","article-title":"Hemophilia growth and development study: caregiver report of youth and family adjustment to HIV disease and immunologic compromise","volume":"28","author":"Bordeaux","year":"2003","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.psc.2007.07.006_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jpepsy\/25.5.309","article-title":"Declining immune function in children and adolescents with hemophilia and HIV infection: effects on neuropsychological performance. Hemophilia growth and development study","volume":"25","author":"Loveland","year":"2000","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.psc.2007.07.006_bib75","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jpepsy\/25.8.545","article-title":"HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the hemophilia growth and development study","volume":"25","author":"Nichols","year":"2000","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.psc.2007.07.006_bib76","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.socscimed.2005.10.032","article-title":"Psychosocial problems of bereaved families of HIV-infected hemophiliacs in Japan","volume":"62","author":"Mizota","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.psc.2007.07.006_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00043426-200103000-00006","article-title":"Nondisclosure of human immunodeficiency virus and hepatitis C virus coinfection in a patient with hemophilia: medical and ethical considerations","volume":"23","author":"Kulkarni","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.psc.2007.07.006_bib78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/pgmj.2004.031161","article-title":"Clozapine, agranulocytosis, and benign ethnic neutropenia","volume":"81","author":"Rajagopal","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.psc.2007.07.006_bib79","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1176\/appi.ajp.162.4.814","article-title":"Clozapine-induced agranulocytosis after 11 years of treatment","volume":"162","author":"Sedky","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib80","series-title":"Textbook of psychopharmacology","first-page":"627","article-title":"Treatment of schizophrenia","author":"Buckley","year":"1995"},{"key":"10.1016\/j.psc.2007.07.006_bib81","first-page":"295","article-title":"Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model","volume":"48","author":"Guzelcan","year":"2006","journal-title":"Tijdschr Psychiatr"},{"key":"10.1016\/j.psc.2007.07.006_bib82","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1345\/aph.1G396","article-title":"Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring","volume":"40","author":"Schulte","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.psc.2007.07.006_bib83","unstructured":"Folkenberg J. Balancing hope with safety. Available at: http:\/\/www.fda.gov\/bbs\/topics\/CONSUMER\/CON00055.html. Accessed June 12, 2007."},{"key":"10.1016\/j.psc.2007.07.006_bib84","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2007.07.006_bib85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00002018-199200071-00007","article-title":"Mechanisms of clozapine-induced agranulocytosis","volume":"7","author":"Gerson","year":"1992","journal-title":"Drug Saf"},{"key":"10.1016\/j.psc.2007.07.006_bib86","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/138945006778226642","article-title":"Psychotropic medications and leukopenia","volume":"7","author":"Sedky","year":"2006","journal-title":"Curr Drug Targets"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2007.07.006_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199200071-00003","article-title":"A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors","volume":"7","author":"Lieberman","year":"1992","journal-title":"Drug Saf"},{"key":"10.1016\/j.psc.2007.07.006_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2006.01720.x","article-title":"Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks","volume":"261","author":"Turner","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.psc.2007.07.006_bib89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1592\/phco.26.9.1307","article-title":"Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature","volume":"26","author":"Mort","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psc.2007.07.006_bib90","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1742-7843.2006.pto_303.x","article-title":"Antidepressants and risk of upper gastrointestinal bleeding","volume":"98","author":"de Abajo","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.psc.2007.07.006_bib91","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00129784-200606040-00004","article-title":"Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery","volume":"6","author":"Andreasen","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.psc.2007.07.006_bib92","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1365-2036.2006.02859.x","article-title":"Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis","volume":"23","author":"Wessinger","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.psc.2007.07.006_bib93","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archfami.7.1.78","article-title":"Selective serotonin reuptake inhibitors: infrequent medical adverse effects","volume":"7","author":"Goldberg","year":"1998","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.psc.2007.07.006_bib94","first-page":"243","article-title":"Pharmacological receptors on blood platelets","volume":"43","author":"Hourani","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.psc.2007.07.006_bib95","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14740338.4.2.337","article-title":"Selective serotonin re-uptake inhibitors and the risk of bleeding","volume":"4","author":"Weinrieb","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.psc.2007.07.006_bib96","first-page":"206","article-title":"Which patients taking SSRIs are at greatest risk of bleeding?","volume":"55","author":"Mansour","year":"2006","journal-title":"J Fam Pract"},{"key":"10.1016\/j.psc.2007.07.006_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","article-title":"Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?","volume":"119","author":"Serebruany","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.psc.2007.07.006_bib98","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4088\/JCP.v64n1215","article-title":"A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients","volume":"64","author":"Weinrieb","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib99","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4088\/JCP.v65n1209","article-title":"Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review","volume":"65","author":"Ramasubbu","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib100","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.WNL.0000154523.21633.0E","article-title":"SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage","volume":"64","author":"Singhal","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2007.07.006_bib101","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.jcp.0000186869.67418.bc","article-title":"Antidepressants, warfarin, and the risk of hemorrhage","volume":"25","author":"Kurdyak","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2007.07.006_bib102","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0033-3182(96)71592-X","article-title":"Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors","volume":"37","author":"Skop","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psc.2007.07.006_bib103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004850-199803000-00006","article-title":"Antidepressant interactions with warfarin","volume":"13","author":"Duncan","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2007.07.006_bib104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0033-3182(99)71206-5","article-title":"Hematologic side effects of psychotropics","volume":"40","author":"Oyesanmi","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psc.2007.07.006_bib105","first-page":"483","article-title":"Agranulocytosis associated with tricyclics","volume":"39","author":"Albertini","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/070674378603100712","article-title":"Tricyclic antidepressant agranulocytosis","volume":"31","author":"Gravenor","year":"1986","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib107","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1192\/bjp.162.5.688","article-title":"Concurrent agranulocytosis and hepatitis secondary to clomipramine therapy","volume":"162","author":"Alderman","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib108","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/pgmj.52.609.472","article-title":"Agranulocytosis and systemic candidiasis following clomipramine therapy","volume":"52","author":"Souhami","year":"1976","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.psc.2007.07.006_bib109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/106002808201600110","article-title":"Desipramine-induced agranulocytosis. A case report","volume":"16","author":"Hardin","year":"1982","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.psc.2007.07.006_bib110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(67)92500-7","article-title":"Agranulocytosis after desipramine","volume":"1","author":"Crammer","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2007.07.006_bib111","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/ajp.150.3.522a","article-title":"Clomipramine-induced agranulocytosis and its treatment with G-CSF","volume":"150","author":"Hunt","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib112","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ajh.2830090412","article-title":"Drug-induced immune thrombocytopenia","volume":"9","author":"Moss","year":"1980","journal-title":"Am J Hematol"},{"key":"10.1016\/j.psc.2007.07.006_bib113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1980.00500580055008","article-title":"Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels","volume":"37","author":"Medina","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2007.07.006_bib114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/BTER:83:2:139","article-title":"Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy","volume":"83","author":"Hager","year":"2001","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.psc.2007.07.006_bib115","series-title":"The pharmacological basis of therapeutics","first-page":"448","article-title":"Drugs effective in the therapy of epilepsys","author":"Rall","year":"1980"},{"key":"10.1016\/j.psc.2007.07.006_bib116","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1176\/ajp.147.5.615","article-title":"Addition of lithium carbonate to carbamazepine: hematological and thyroid effects","volume":"147","author":"Kramlinger","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2007.07.006_bib117","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00228-006-0104-4","article-title":"The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose","volume":"62","author":"Herman","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.psc.2007.07.006_bib118","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1993.tb04218.x","article-title":"Changes in red blood cells with valproate therapy","volume":"88","author":"Ozkara","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.psc.2007.07.006_bib119","series-title":"Textbook of psychopharmacology","first-page":"680","article-title":"Treatment of childhood and adolescent disorders","author":"Dulcan","year":"1995"},{"key":"10.1016\/j.psc.2007.07.006_bib120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.psc.2007.07.006_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1528-1157.2002.31801.x","article-title":"Agranulocytosis associated with lamotrigine in a patient with low-grade glioma","volume":"43","author":"Fadul","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.psc.2007.07.006_bib122","first-page":"S23","article-title":"Clinical efficacy and safety of gabapentin","volume":"44","author":"Ramsay","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2007.07.006_bib123","unstructured":"Micromedex. 2007. Healthcare Series Integrated Index."},{"key":"10.1016\/j.psc.2007.07.006_bib124","series-title":"Mosby drug consult","year":"2007"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X07000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X07000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T02:49:24Z","timestamp":1557024564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X07000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0193953X07000767"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2007.07.006","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}